Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Why the Bears Are Wrong About Keryx Biopharmaceuticals Stock
Why the Bears Are Wrong About Keryx Biopharmaceuticals Stock
I haven't exactly been a bull when it comes to Keryx Biopharmaceuticals (NASDAQ: KERX). For starters, it's not even a biotech company (trying for the old "bait-and-switch" move, eh?). It doesn't....
3 Healthcare Dividend Stocks Ideal for Retirees
3 Healthcare Dividend Stocks Ideal for Retirees
What does an ideal investment portfolio look like for retirees? The answer to that question varies based on each individual's financial position and goals. However, nearly every retiree wants to....
3 Healthcare Dividend Stocks Ideal for Retirees
3 Healthcare Dividend Stocks Ideal for Retirees
What does an ideal investment portfolio look like for retirees? The answer to that question varies based on each individual's financial position and goals. However, nearly every retiree wants to....
Medicare Is Changing. Here Are 3 Things Investors Need to Know
Medicare Is Changing. Here Are 3 Things Investors Need to Know
I recently attended a conference at the prestigious Brookings Institute that was all about Medicare payment reform. The event drew an older crowd, with suit-and-tie attire and coffee that was....
Medicare Is Changing. Here Are 3 Things Investors Need to Know
Medicare Is Changing. Here Are 3 Things Investors Need to Know
I recently attended a conference at the prestigious Brookings Institute that was all about Medicare payment reform. The event drew an older crowd, with suit-and-tie attire and coffee that was....
Medicare Is Changing. Here Are 3 Things Investors Need to Know
Medicare Is Changing. Here Are 3 Things Investors Need to Know
I recently attended a conference at the prestigious Brookings Institute that was all about Medicare payment reform. The event drew an older crowd, with suit-and-tie attire and coffee that was....
3 Monster Stocks in the Making
3 Monster Stocks in the Making
Halloween is right around the corner, which makes it the perfect time to look for monster stocks in the making. What are some characteristics these stocks might have? Leading market positions,....
Why Viacom, DaVita, and K2M Group Holdings Slumped Today
Why Viacom, DaVita, and K2M Group Holdings Slumped Today
Monday was a down day on Wall Street, with the Dow, S&P 500, and Nasdaq Composite all giving up between 0.1% and 0.2%. The trading session was relatively quiet on the Columbus Day holiday,....
2 Stocks Your Children Will Brag About Someday
2 Stocks Your Children Will Brag About Someday
While few and far between, some businesses are so strong that they can create wealth for generations. That's why we Fools think it's a worthwhile endeavor to constantly search the markets for....
2 Stocks Your Children Will Brag About Someday
2 Stocks Your Children Will Brag About Someday
While few and far between, some businesses are so strong that they can create wealth for generations. That's why we Fools think it's a worthwhile endeavor to constantly search the markets for....
Here's What Lifted Arena Pharmaceuticals, Inc. Stock in September
Here's What Lifted Arena Pharmaceuticals, Inc. Stock in September
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) continued its monster climb this year with a 10% gain in September, according to data from S&P Global Market Intelligence. Preclinical results....
Why K2M Group Holdings Inc. Sank Today
Why K2M Group Holdings Inc. Sank Today
K2M Group Holdings (NASDAQ: KTWO) is down 18.6% at 1:07 p.m. EDT after the company released disappointing preliminary revenue for the third quarter, with revenue up just 6% year over year. The....
The 1 Event That Sent NewLink Genetics Corporation Soaring 25% in September
The 1 Event That Sent NewLink Genetics Corporation Soaring 25% in September
Shares of NewLink Genetics (NASDAQ: NLNK), a small-cap clinical-stage drug developer focused on therapies to treat cancer, skyrocketed by 25% in September, according to data from S&P Global....
The 1 Event That Sent NewLink Genetics Corporation Soaring 25% in September
The 1 Event That Sent NewLink Genetics Corporation Soaring 25% in September
Shares of NewLink Genetics (NASDAQ: NLNK), a small-cap clinical-stage drug developer focused on therapies to treat cancer, skyrocketed by 25% in September, according to data from S&P Global....
13.000 Punkte im Dax – und dann?
13.000 Punkte im Dax – und dann?
13.000 Punkte im Dax sind zum Greifen nahe und jeder wartet gespannt, wann genau die Marke überschritten wird. Was passiert, wenn die Schwelle überschritten wird? Befinden wir uns nicht schon....
3 Stocks That Could Lose You a Lot of Money
3 Stocks That Could Lose You a Lot of Money
Even the most successful investors swing and miss from time to time. It's a big, messy world out there, and no one has all the information they need to scout out only winning stocks for their....
Roundtable: 1 Stock Retirees Should Consider
Roundtable: 1 Stock Retirees Should Consider
Time magazine declares that "70 is the new 50." And just because you're retired doesn't mean it's time to stop investing. In fact, retirement may be the best time to invest in stocks. Seriously,....
Bitcoin vs. Biotech: Which Is the Smarter Investment?
Bitcoin vs. Biotech: Which Is the Smarter Investment?
Bitcoin just might be the most controversial topic in the investing world. Supporters think the cryptocurrency has the potential to disrupt the financial industry. They also point to bitcoin's....
Bitcoin vs. Biotech: Which Is the Smarter Investment?
Bitcoin vs. Biotech: Which Is the Smarter Investment?
Bitcoin just might be the most controversial topic in the investing world. Supporters think the cryptocurrency has the potential to disrupt the financial industry. They also point to bitcoin's....
Bitcoin vs. Biotech: Which Is the Smarter Investment?
Bitcoin vs. Biotech: Which Is the Smarter Investment?
Bitcoin just might be the most controversial topic in the investing world. Supporters think the cryptocurrency has the potential to disrupt the financial industry. They also point to bitcoin's....
3 Best Healthcare Dividend Aristocrat Stocks You Can Buy Right Now
3 Best Healthcare Dividend Aristocrat Stocks You Can Buy Right Now
"Dividend Aristocrat" just has a nice ring to it, doesn't it? The "dividend" part sounds great because it means a stock is going to pay you to own it. "Aristocrat" conveys nobility, an elite....
3 Best Healthcare Dividend Aristocrat Stocks You Can Buy Right Now
3 Best Healthcare Dividend Aristocrat Stocks You Can Buy Right Now
"Dividend Aristocrat" just has a nice ring to it, doesn't it? The "dividend" part sounds great because it means a stock is going to pay you to own it. "Aristocrat" conveys nobility, an elite....
AbbVie's Fast Becoming a Top Stock to Buy Now
AbbVie's Fast Becoming a Top Stock to Buy Now
AbbVie Inc.'s (NYSE: ABBV) making considerable progress toward reducing its reliance on its top-selling autoimmune disease drug, Humira, and recent patent news that could sideline Humira....
AbbVie's Fast Becoming a Top Stock to Buy Now
AbbVie's Fast Becoming a Top Stock to Buy Now
AbbVie Inc.'s (NYSE: ABBV) making considerable progress toward reducing its reliance on its top-selling autoimmune disease drug, Humira, and recent patent news that could sideline Humira....
Here's Why Juno Therapeutics Stock May Still Be Worth Buying
Here's Why Juno Therapeutics Stock May Still Be Worth Buying
Juno Therapeutics (NASDAQ: JUNO), a clinical-stage adoptive cell therapy company, saw its shares rise by 7% last month, according to data from S&P Global Market Intelligence.The biotech's....